KAHALALIDE F FORMULATION

European patent · EP1330258 · Deleted

Register entry

Publication number
EP1330258
Application number
EP01978654
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Oct 31, 2001
Published
Jul 30, 2003
Granted
Dec 28, 2005
Deleted
Oct 31, 2011
Reason
Annual fee unpaid
IPC classes
A61K 38/15 (2006.01)
A61K 9/19 (2006.01)
A61P 35/00 (2006.01)
Priority
US 244471 P 31.10.2000
US 246229 P 06.11.2000
US 348449 P 19.10.2001
PCT application
PCT/GB2001/004821 31.10.2001
PCT publication
WO2002/036145 10.05.2002
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 23, 2012

    Deleted, fee unpaid

    Published in Swissreg on 23.05.2012

  2. Apr 15, 2008

    Address changed

    Representative
    Ritscher & Partner AG, Zollikerstrasse 19, 8702 Zollikon → Ritscher & Partner AG, Resirain 1, 8125 Zollikerberg

    Published in +pat+ No 7 in 2008

  3. Apr 13, 2006

    Agent entered

    Representative
    Ritscher & Partner AG, Zollikerstrasse 19, 8702 Zollikon

    Published in +pat+ No 7 in 2006

  4. Dec 30, 2005

    Granted

    Published in +pat+ No 24 in 2005

Parties

Holder

PHARMA MAR, S.A.

Pharma Mar, S.A.

Calle de la Calera, 3 Poligono Industrial de Tres Cantos, 28760 Madrid, ES

Agent

Kasche & Partner AG

Ritscher & Partner AG

Resirain 1, 8125 Zollikerberg

Inventor

FAIRCLOTH, Glynn Thomas, PharmaMar USA, Inc.

Cambridge, MA 02139-4616, US

NUYEN, Bastian, Cancer Inst./Slotervaart Hospit.,

Louwesweg 6, Nl-1066 EC Amsterdam, NL

WEITMAN, Steve, Institute for Drug Development

San Antonio, TX 78245-3217, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.